News of Note—Chickenpox outbreak, GeoVax and more

newspaper
In this week's news of note, GeoVax entered a new immunotherapy collaboration. (Pixabay)

Here is some other vaccine news of note for the week:

> A chickenpox outbreak in a North Carolina anti-vaccination hotbed is the state's worst in two decades. The Washington Post article

> GeoVax entered a collaboration with Leidos to test its vaccine candidates in conjunction with Leidos-developed checkpoint inhibitors. Release

Webinar

Striving for Zero in Quality & Manufacturing

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. This on-demand webinar discusses the role that content management plays in pharmaceutical manufacturing to help companies reach the goal of zero in Quality and Manufacturing.

> In a preclinical study, a DNA vaccine lowered the buildup of tau and beta-amyloid proteins associated with Alzheimer's disease. Release

Read more on

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.